Sale!

Evrysdi (risdiplam)

Original price was: $6.00.Current price is: $5.00.

Evrysdi is a survival of motor neuron 2 (SMN2) splicing modifier indicated for the treatment of spinal muscular atrophy (SMA) in pediatric and adult patients.

Reviews

There are no reviews yet.

Be the first to review “Evrysdi (risdiplam)”

Your email address will not be published. Required fields are marked *